Open AccessCost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic Treatment
Author(s) -
Yoram Bouhnik,
Raja Atreya,
Daniel Casey,
Michał Górecki,
Deborah Baik,
Sang Wook Yoon,
Taek Sang Kwon,
Minyoung Jang
Publication year - 2022
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izac160
Subject(s) - vedolizumab , medicine , infliximab , inflammatory bowel disease , ulcerative colitis , adalimumab , crohn's disease , adverse effect , cost effectiveness , surgery , disease , risk analysis (engineering)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom